Nature CommunicationsCD73 disruption with tumor-specific CRISPR/Cas9 nanoparticles reduces adenosine-mediated immunosuppression and amplifies response to chemotherapyXinhong SunYujing SangTengfei HeMeng ZhengYan ZouAndy Tay2026-09-08Full textDOI https://doi.org/10.1038/s41467-026-77547-4